These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38983799)

  • 41. The effect of luteal GnRH antagonist on moderate and severe early ovarian hyperstimulation syndrome during in vitro fertilization treatment: a prospective cohort study.
    Zeng C; Shang J; Jin AM; Wu PL; Li X; Xue Q
    Arch Gynecol Obstet; 2019 Jul; 300(1):223-233. PubMed ID: 31004220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obstetric outcomes following ovarian hyperstimulation syndrome in IVF - a comparison with uncomplicated fresh and frozen transfer cycles.
    Ganer Herman H; Mizrachi Y; Horowitz E; Weissman A; Sabban B; Gluck O; Raziel A; Kovo M
    BMC Pregnancy Childbirth; 2022 Jul; 22(1):573. PubMed ID: 35850741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
    Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Freitas V
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006105. PubMed ID: 19370625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The number of oocytes retrieved during IVF: a balance between efficacy and safety.
    Magnusson Å; Källen K; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2018 Jan; 33(1):58-64. PubMed ID: 29136154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Annual incidence of severe ovarian hyperstimulation syndrome.
    Tomás C; Colmorn L; Rasmussen S; Lidegaard Ø; Pinborg A; Andersen AN
    Dan Med J; 2021 Jan; 68(2):. PubMed ID: 33543701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of low-dose aspirin on the development of ovarian hyperstimulation syndrome and outcomes of assisted reproductive techniques in the women with PCOS, a randomized double-blinded clinical trial.
    Namavar Jahromi B; Zolghadri J; Rahmani E; Alipour S; Anvar Z; Zarei A; Keramati P
    Taiwan J Obstet Gynecol; 2019 Mar; 58(2):255-260. PubMed ID: 30910149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association between the number of oocytes retrieved for IVF, perinatal outcome and obstetric complications.
    Magnusson Å; Wennerholm UB; Källén K; Petzold M; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2018 Oct; 33(10):1939-1947. PubMed ID: 30124838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology.
    Bühler K; Naether OG; Bilger W
    Reprod Biol Endocrinol; 2014 Jan; 12():6. PubMed ID: 24423045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of assisted reproductive technologies on maternal and neonatal outcomes in early preterm deliveries.
    Di Tommaso M; Sisti G; Colombi I; Seravalli V; Magro Malosso ER; Vannuccini S; Petraglia F
    J Gynecol Obstet Hum Reprod; 2019 Dec; 48(10):845-848. PubMed ID: 30898633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Follicular aspiration versus coasting for ovarian hyper-stimulation syndrome prevention.
    Bushaqer NJ; Dayoub NM; AlHattali KK; Ayyoub HA; AlFaraj SS; Hassan SN
    Saudi Med J; 2018 Mar; 39(3):290-295. PubMed ID: 29543308
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Laparoscopic ovarian drilling versus GnRH antagonist combined with cabergoline as a prophylaxis against the re-development of ovarian hyperstimulation syndrome.
    Seyam E; Hefzy E
    Gynecol Endocrinol; 2018 Jul; 34(7):616-622. PubMed ID: 29334275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute Kidney Injury Due to Ovarian Hyperstimulation Syndrome.
    Abou Arkoub R; Xiao CW; Claman P; Clark EG
    Am J Kidney Dis; 2019 Mar; 73(3):416-420. PubMed ID: 30600106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.
    Al-Inany HG; Youssef MA; Ayeleke RO; Brown J; Lam WS; Broekmans FJ
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD001750. PubMed ID: 27126581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.
    D'Angelo A; Amso NN; Hassan R
    Cochrane Database Syst Rev; 2017 May; 5(5):CD002811. PubMed ID: 28535578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical characteristics of severe late-onset ovarian hyperstimulation syndrome and its impact on the live birth outcome of IVF-ET].
    Ma XW; Yin JW; Yang R; Yang S; Li J; Wang Y; Li R
    Zhonghua Fu Chan Ke Za Zhi; 2022 Sep; 57(9):678-685. PubMed ID: 36177579
    [No Abstract]   [Full Text] [Related]  

  • 56. Pregnancy outcomes in patients with late-onset severe OHSS following different methods of ascetic fluid drainage and a comparison with non-OHSS IVF patients.
    Ren Y; Li R; Yang S; Yang R; Song D
    Arch Gynecol Obstet; 2022 Jun; 305(6):1587-1594. PubMed ID: 35059793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.
    Kamath MS; Maheshwari A; Bhattacharya S; Lor KY; Gibreel A
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008528. PubMed ID: 29096046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interventions to prevent or reduce the incidence and severity of ovarian hyperstimulation syndrome: a systematic umbrella review of the best clinical evidence.
    Palomba S; Costanzi F; Nelson SM; Caserta D; Humaidan P
    Reprod Biol Endocrinol; 2023 Jul; 21(1):67. PubMed ID: 37480081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk Factors and Methods for Predicting Ovarian Hyperstimulation Syndrome (OHSS) in the in vitro Fertilization.
    Pakhomov SP; Orlova VS; Verzilina IN; Sukhih NV; Nagorniy AV; Matrosova AV
    Arch Razi Inst; 2021 Nov; 76(5):1461-1468. PubMed ID: 35355759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ovarian Hyperstimulation Syndrome Is Associated with a High Secondary Sex Ratio in Fresh IVF Cycles with Cleavage-Stage Embryo Transfer: Results for a Cohort Study.
    Jia Q; Fang L; Wang Z; Wu Z; Yan Y; Liu B; Cheng JC; Sun YP
    Reprod Sci; 2021 Dec; 28(12):3341-3351. PubMed ID: 34081318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.